Phase II Study of combination chemotherapy with SPT in patient with HER2(+) advanced gastric cancer
- Conditions
- HER2(+) advanced gastric cancer
- Registration Number
- JPRN-UMIN000011595
- Lead Sponsor
- Kawasaki Gastric Cancer Group(KGCG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Not provided
1) Patients with a history of serious drug hypersensitivity 2) Patients who are received administration of flucytosine 3) Patients who are received continuous administration of phenytoin, or warfarin. 4) Patients with active infection 5) Patients with serious complication 6) Patients with diarrhea (4 or more times per day or watery diarrhea) 7) Patients with massive ascites or massive pleural effusion retention. 8) Patients with serious heart disease 9) Uncontrolled hypertension 10) Second primary malignancy 11) Women in pregnancy, at risk of pregnancy, hoping to become pregnant 12) Men who want their partners to become pregnant 13) Any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method